Thursday, 21 May 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 21 May 2026
News

New CEO announced after 2 years

Posted 21 May 2026 PM

Two years after the passing of Vectus Biosystems’ CEO and Co-Founder, Dr Karen Duggan, strategic investment consultant, Dr Tara Speranza, who has been working with the company over the past 9 months has taken the helm.

Before Duggan tragically passed to an illness, she expressed her desire to see the technologies that she helped pioneer utilised for the benefit of humanity.

To see the whole article, please login

Popular

Pharma spend on HCPs doubles
Which Drs really distrust pharma?
World's Most Innovative Pharma is...
High-flyer exits corporate world
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home